Please assess the completion status of the following clinical trial:

Trial Title: Acetaminophen Before Vaccines for Infants Study (AVIS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Child is a current Group Health enrollee.~2. Child will be seen at a Group Health clinic for a Well Child visit that is expected to include 2 or more vaccines after 6 wks and before 10 months of age.~Exclusion Criteria:~1. If child was born at less than 36 weeks of gestation, the child is not eligible until 4 months of age or older.~2. If the child's birth weight was less than 5.5 pounds (2500 grams), the child is not eligible until 4 months of age or older.

- Gender: ALL
- Minimum Age: 6 Weeks
- Maximum Age: 9 Months
- Healthy Volunteers: t

Study Arms:
- Acetaminophen (Type: ACTIVE_COMPARATOR): Children were randomized 1:1 to receive up to five doses of acetaminophen (10-15mg per kg) or placebo following routine vaccinations.
- Placebo (Type: PLACEBO_COMPARATOR): Children were randomized 1:1 to receive up to five doses of acetaminophen (10-15mg per kg) or placebo following routine vaccinations.

Based on this trial design, predict the completion outcome and termination type (if applicable).